Orthofix Medical Inc. - Common stock, $0.10 par value per share (OFIX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2018 to Q4 2025

Type / Class
Equity / Common stock, $0.10 par value per share
Symbol
OFIX on Nasdaq
Shares outstanding
39,581,465
Price per share
$15.25
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
35,152,620
Total reported value
$532,914,541
% of total 13F portfolios
0%
Share change
-43,169
Value change
-$314,975
Number of holders
140
Price from insider filings
$15.25
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Orthofix Medical Inc. - Common stock, $0.10 par value per share (OFIX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ENGINE CAPITAL, L.P. 11% +18% $60,331,211 +$8,846,670 4,251,671 +17% Engine Capital Management, LP 07 May 2025
Juniper Investment Company, LLC 9.6% +18% $57,715,409 +$8,255,328 3,784,617 +17% Juniper Investment Company, LLC 11 Feb 2026
BlackRock, Inc. 7.7% $42,416,393 2,989,175 BlackRock, Inc. 31 Mar 2025
ARMISTICE CAPITAL, LLC 6.7% +17% $40,382,000 +$6,283,000 2,648,000 +18% Armistice Capital, LLC 31 Dec 2025

As of 31 Dec 2025, 140 institutional investors reported holding 35,152,620 shares of Orthofix Medical Inc. - Common stock, $0.10 par value per share (OFIX). This represents 89% of the company’s total 39,581,465 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Orthofix Medical Inc. - Common stock, $0.10 par value per share (OFIX) together control 81% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Engine Capital Management, LP 11% 4,252,921 0% 8.9% $64,474,282
Rubric Capital Management LP 9.4% 3,721,715 0% 0.67% $56,421,199
Juniper Investment Company, LLC 8.9% 3,510,333 +23% 18% $53,216,648
PARADIGM CAPITAL MANAGEMENT INC/NY 8.3% 3,304,899 -1.2% 2.1% $50,102,269
BlackRock, Inc. 7.9% 3,139,838 +0.07% 0% $47,599,943
ARMISTICE CAPITAL, LLC 6.7% 2,648,000 +18% 0.98% $40,143,680
VANGUARD GROUP INC 5.8% 2,304,928 +0.98% 0% $34,942,708
MILLENNIUM MANAGEMENT LLC 3.6% 1,441,267 -2.3% 0.02% $21,849,608
Philosophy Capital Management LLC 2.6% 1,015,194 +15% 1.8% $15,390,341
DIMENSIONAL FUND ADVISORS LP 2.4% 949,087 -17% 0% $14,388,756
GEODE CAPITAL MANAGEMENT, LLC 2.4% 947,189 +0.62% 0% $14,362,333
STATE STREET CORP 2.2% 857,690 -1.7% 0% $13,002,580
AYAL Capital Advisors Ltd 1.9% 742,372 -11% 6.2% $11,254,360
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.84% 333,805 -0.59% 0% $5,060,484
Nuveen, LLC 0.84% 332,042 -38% 0% $5,033,757
NORTHERN TRUST CORP 0.81% 318,646 -7.3% 0% $4,830,674
BANK OF AMERICA CORP /DE/ 0.66% 261,386 -12% 0% $3,962,611
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.65% 256,094 -18% 0% $3,882,385
JPMORGAN CHASE & CO 0.6% 237,273 -8% 0% $3,597,058
GABELLI FUNDS LLC 0.59% 235,303 +0.43% 0.02% $3,567,193
ACADIAN ASSET MANAGEMENT LLC 0.57% 226,590 +33% 0.01% $3,432,000
MORGAN STANLEY 0.57% 224,642 +30% 0% $3,405,571
GOLDMAN SACHS GROUP INC 0.53% 211,419 -26% 0% $3,205,112
TUDOR INVESTMENT CORP ET AL 0.51% 202,606 -6.7% 0.02% $3,071,507
Russell Investments Group, Ltd. 0.5% 197,930 +4.3% 0% $3,000,614

Institutional Holders of Orthofix Medical Inc. - Common stock, $0.10 par value per share (OFIX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 35,152,620 $532,914,541 -$314,975 $15.16 140
2025 Q3 35,209,561 $515,431,059 -$6,954,498 $14.64 142
2025 Q2 35,918,321 $400,488,868 +$22,756,116 $11.15 156
2025 Q1 33,187,409 $541,283,546 +$2,357,038 $16.31 158
2024 Q4 33,046,769 $576,999,751 -$25,102,994 $17.46 149
2024 Q3 34,675,214 $541,637,314 -$18,041,209 $15.62 148
2024 Q2 35,567,022 $471,619,624 -$3,810,664 $13.26 129
2024 Q1 35,794,867 $519,708,553 +$407,953 $14.52 136
2023 Q4 35,824,640 $482,922,201 +$19,451,575 $13.48 154
2023 Q3 34,171,175 $439,457,256 +$12,134,957 $12.86 159
2023 Q2 33,051,411 $596,926,163 +$9,962,445 $18.06 148
2023 Q1 32,569,069 $545,548,927 +$197,201,126 $16.75 160
2022 Q4 20,484,051 $420,501,877 +$16,183,620 $20.53 152
2022 Q3 19,713,019 $376,732,898 -$5,543,784 $19.11 139
2022 Q2 19,816,453 $466,601,660 +$6,575,599 $23.54 127
2022 Q1 19,416,935 $634,819,749 -$541,500 $32.70 146
2021 Q4 19,450,587 $604,233,953 -$9,830,363 $31.09 131
2021 Q3 19,555,033 $746,013,245 +$21,323,967 $38.12 141
2021 Q2 18,994,693 $761,880,787 -$4,418,230 $40.11 134
2021 Q1 19,021,142 $824,356,370 +$2,402,671 $43.35 137
2020 Q4 19,028,176 $817,839,883 +$10,159,437 $42.98 138
2020 Q3 18,800,230 $585,684,972 +$7,467,697 $31.14 132
2020 Q2 18,488,760 $591,010,560 +$1,189,132 $32.00 139
2020 Q1 18,523,626 $518,625,834 -$6,413,507 $28.01 141
2019 Q4 18,572,262 $857,611,846 -$5,131,906 $46.18 150
2019 Q3 18,481,155 $979,844,393 +$21,155,365 $53.02 153
2019 Q2 18,082,971 $956,145,616 +$4,470,817 $52.88 151
2019 Q1 18,397,613 $1,037,760,208 +$14,433,303 $56.41 164
2018 Q4 18,156,699 $953,170,632 -$3,721,577 $52.49 166
2018 Q3 18,196,817 $1,051,927,063 +$1,012,496,995 $57.81 157
2018 Q2 674,286 $38,309,830 +$38,300,000 $56.82 12
2018 Q1 173 $10,169 +$10,169 $58.78 1